P. Pichňa
Impact in
-
- Antibiotic Use and Resistance
- Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- Bacterial Identification and Susceptibility Testing 11
- Oncology 14
- Neutropenia and Cancer Infections 14
P. Pichňa
20 papers receiving 285 citations
Peers
Comparison fields: 5 of 47
- Applied Microbiology and Biotechnology 34
- Clinical Biochemistry 89
- Infectious Diseases 192
- Drug Discovery 1
- Critical Care and Intensive Care Medicine 29
Countries citing papers authored by P. Pichňa
This map shows the geographic impact of P. Pichňa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Pichňa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Pichňa more than expected).
Fields of papers citing papers by P. Pichňa
This network shows the impact of papers produced by P. Pichňa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Pichňa. The network helps show where P. Pichňa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside P. Pichňa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 9 | |
| 2 | 2002 | 110 | |
| 3 | 2001 | 27 | |
| 4 | 2000 | 3 | |
| 5 | 1998 | 9 | |
| 6 | 1998 | 23 | |
| 7 | Inappropriate antibiotic therapy in febrile cancer patients with bacteremia. | 1998 | 3 |
| 8 | 1997 | 16 | |
| 9 | 1997 | 17 | |
| 10 | 1997 | 11 | |
| 11 | 1997 | 7 | |
| 12 | 1997 | 16 | |
| 13 | Bacteremia in neutropenic versus nonneutropenic cancer patients: etiology and outcome in 401 episodes. | 1997 | 4 |
| 14 | 1996 | 3 | |
| 15 | 1996 | 3 | |
| 16 | Bloodstream infections due to anaerobic bacteria in cancer patients: epidemiology, etiology, risk factors, clinical presentation and outcome of anaerobic bacteremia. | 1996 | 11 |
| 17 | Breakthrough bacteraemic and fungaemic episodes during antimicrobial prophylaxis and therapy in cancer patients: analysis of risk factors, etiology, therapy and outcome in 123 episodes. | 1996 | 1 |
| 18 | 1995 | 23 | |
| 19 | Fluconazole versus itraconazole in therapy of oropharyngeal candidiasis in cancer patients: a prospective comparative randomized trial. | 1995 | 5 |
| 20 | 1994 | 5 |
About P. Pichňa
P. Pichňa is a scholar working on Clinical Biochemistry, Oncology, Applied Microbiology and Biotechnology, Molecular Medicine and Infectious Diseases, having authored 20 papers that have together received 306 indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (14 papers), Bacterial Identification and Susceptibility Testing (11 papers), Antifungal resistance and susceptibility (6 papers), Fungal Infections and Studies (3 papers), Oral health in cancer treatment (2 papers), Antibiotic Resistance in Bacteria (2 papers), Mycobacterium research and diagnosis (2 papers) and Urinary Tract Infections Management (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (34 citations), Clinical Biochemistry (89 citations), Infectious Diseases (192 citations), Drug Discovery (1 citation) and Critical Care and Intensive Care Medicine (29 citations). P. Pichňa has collaborated with scholars based in Slovakia, United States and Malaysia. Frequent co-authors include Daniel Lew, Didier Pittet, Jorge Garbino, Peter Rohner, S. Špánik, J. Trupl, E. Kukučková, A. Kunová, Jozef Šufliarský and V. Krčméry. Their work appears in journals such as Chemotherapy, Supportive Care in Cancer, International Journal of Antimicrobial Agents, Medicine and Clinical Nutrition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.